AllianceBernstein’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-39,560
| Closed | -$879K | – | 3278 |
|
|
2025
Q1 | $879K | Hold |
39,560
| – | – | ﹤0.01% | 2304 |
|
|
2024
Q4 | $782K | Hold |
39,560
| – | – | ﹤0.01% | 2439 |
|
|
2024
Q3 | $989K | Buy |
+39,560
| New | +$989K | ﹤0.01% | 2336 |
|
|
2024
Q2 | – | Sell |
-39,560
| Closed | -$781K | – | 3268 |
|
|
2024
Q1 | $781K | Hold |
39,560
| – | – | ﹤0.01% | 2392 |
|
|
2023
Q4 | $694K | Sell |
39,560
-2,340
| -6% | -$41K | ﹤0.01% | 2448 |
|
|
2023
Q3 | $728K | Hold |
41,900
| – | – | ﹤0.01% | 2375 |
|
|
2023
Q2 | $590K | Hold |
41,900
| – | – | ﹤0.01% | 2546 |
|
|
2023
Q1 | $451K | Hold |
41,900
| – | – | ﹤0.01% | 2614 |
|
|
2022
Q4 | $628K | Hold |
41,900
| – | – | ﹤0.01% | 2511 |
|
|
2022
Q3 | $538K | Buy |
41,900
+5,700
| +16% | +$73.2K | ﹤0.01% | 2607 |
|
|
2022
Q2 | $351K | Buy |
36,200
+6,200
| +21% | +$60.1K | ﹤0.01% | 2823 |
|
|
2022
Q1 | $298K | Buy |
30,000
+100
| +0.3% | +$993 | ﹤0.01% | 2863 |
|
|
2021
Q4 | $352K | Buy |
29,900
+1,000
| +3% | +$11.8K | ﹤0.01% | 2883 |
|
|
2021
Q3 | $329K | Sell |
28,900
-3,700
| -11% | -$42.1K | ﹤0.01% | 2919 |
|
|
2021
Q2 | $454K | Buy |
32,600
+10,600
| +48% | +$148K | ﹤0.01% | 2839 |
|
|
2021
Q1 | $407K | Sell |
22,000
-7,700
| -26% | -$142K | ﹤0.01% | 2749 |
|
|
2020
Q4 | $525K | Buy |
29,700
+1,400
| +5% | +$24.7K | ﹤0.01% | 2556 |
|
|
2020
Q3 | $434K | Sell |
28,300
-1,200
| -4% | -$18.4K | ﹤0.01% | 2589 |
|
|
2020
Q2 | $752K | Buy |
29,500
+3,600
| +14% | +$91.8K | ﹤0.01% | 2348 |
|
|
2020
Q1 | $401K | Buy |
25,900
+6,700
| +35% | +$104K | ﹤0.01% | 2456 |
|
|
2019
Q4 | $212K | Hold |
19,200
| – | – | ﹤0.01% | 2894 |
|
|
2019
Q3 | $163K | Buy |
19,200
+5,300
| +38% | +$45K | ﹤0.01% | 2978 |
|
|
2019
Q2 | $188K | Buy |
+13,900
| New | +$188K | ﹤0.01% | 2979 |
|
|
2019
Q1 | – | Sell |
-8,800
| Closed | -$247K | – | 3125 |
|
|
2018
Q4 | $247K | Buy |
+8,800
| New | +$247K | ﹤0.01% | 2804 |
|